Sanjiv Patel

President and CEO

Sanjiv Patel (President and CEO) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Relay Therapeutics, Inc. (RLAY). The largest single filing was $980K of RLAY (48,199 sh × $20.33, as filed), executed Aug 17.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 5 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$3.6M

shares × price, as filed

Last traded

Sep 8

Filed Sep 9

Median ADV $74.0M across their filed names

Open performance→

Volume by month

Buys $0 Sells $7.0M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 5 filings

Sector per market data · by filing · past 12 months

Most traded names

RLAY

Relay Therapeutics, Inc. RLAY · 0 buys · 10 sells 10 filings

Recent filings

RLAYSALE Relay Therapeutics, Inc. View filing → $913K
48,199 sh × $18.94
Exec Sep 8
Filed Sep 9 · 4:12 PM ET RLAYSALE Relay Therapeutics, Inc. View filing → $980K
48,199 sh × $20.33
Exec Aug 17
Filed Aug 18 · 4:17 PM ET RLAYSALE Relay Therapeutics, Inc. View filing → $944K
48,199 sh × $19.58
Exec Jul 7
Filed Jul 8 · 5:08 PM ET RLAYSALE Relay Therapeutics, Inc. View filing → $338K
43,168 sh × $7.82
Exec Jan 6
Filed Jan 7 · 5:30 PM ET RLAYSALE Relay Therapeutics, Inc. View filing → $435K
62,073 sh × $7.00
Exec Nov 3 2025
Filed Nov 4 2025 · 5:30 PM ET RLAYSALE Relay Therapeutics, Inc. View filing → $153K
42,740 sh × $3.57
Exec Jul 9 2025
Filed Jul 10 2025 · 5:30 PM ET RLAYSALE Relay Therapeutics, Inc. View filing → $127K
42,769 sh × $2.97
Exec Apr 23 2025
Filed Apr 24 2025 · 5:30 PM ET RLAYSALE Relay Therapeutics, Inc. View filing → $818K
215,506 sh across 2 lots
Exec Feb 11 2025
Filed Feb 13 2025 · 5:30 PM ET More filings →